残胃癌和胃癌复发的临床病理学特征及预后分析

doi:10.3969/j.issn.1005-6483.2020.10.017

摘要/Abstract

摘要： 目的对比残胃癌和胃癌复发的临床病理学特征及预后情况。
方法我院2009年1月～2019年1月间收治的胃癌病人162例，均行胃大部切除术。根据癌症发生原因分为残胃癌组（80例）和胃癌复发组（82例），对两组病人的临床病理学特征和预后进行回顾性分析。
结果残胃癌组病人肿瘤大小、病理学分期、组织分化程度、远处转移等病理学特征均优于胃癌复发组（P＜0.05）；Cox回归分析结果显示，病理学分期、组织分化程度、远处转移均是影响残胃癌、胃癌复发病人预后的独立因素（P＜0.05）；残胃癌病人总体生存时间为（43.92±4.33）个月，胃癌复发病人总体生存时间为（25.48±3.71）个月，差异有统计学意义（P＜0.05）。
结论残胃癌的临床病理学特征要优于复发胃癌，残胃癌病人生存时间长于胃癌复发病人，预后更好。

关键词: 残胃癌, 复发, 表达, 病理特征, 预后

Abstract: Objective Comparison of clinicopathological features and prognosis of remnant gastric cancer and gastric cancer recurrence.
Methods 62 patients with gastric cancer who had undergone major gastrectomy from January 2009 to January 2019 in our hospital were selected as the research object，they are divided into gastric cancer group (80 cases) and gastric cancer recurrence group (82 cases).Retrospective analysis of clinicopathological characteristics and prognosis data of two groups of patients.
Results The tumor size，pathological stage，degree of tissue differentiation，distant metastasis and other pathological characteristics of patients with gastric cancer group were significantly better than those with gastric cancer（P＜0.05）.Cox regression analysis was performed，and the results showed that pathological stage，degree of tissue differentiation，and distant metastasis were independent factors affecting the prognosis of patients with residual gastric cancer and gastric cancer recurrence（P＜0.05）.The overall survival time of patients with residual gastric cancer is (43.92±4.33) months，and the overall survival time of patients with recurrent gastric cancer is (25.48±3.71) months.the difference between the two groups is statistically significant（P＜0.05）.
Conclusion The clinical and pathological characteristics of residual gastric cancer are better than those of gastric cancer recurrence，and the survival time of patients with residual gastric cancer is significantly longer than that of patients with gastric cancer recurrence，and the prognosis is better.

Key words: residual gastric cancer, recurrence, expression, pathological features, prognosis

宋坤胡应明蒋成明樊俊. 残胃癌和胃癌复发的临床病理学特征及预后分析[J]. 临床外科杂志, 2020, 28(10): 955-957.

SONG Kun, HU Yingming, JIANG Chengming, et al.. Comparison of clinicopathological features and prognosis of recurrent gastric cancer and gastric cancer recurrence[J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(10): 955-957.

参考文献

相关文章 15

[1]	陈革陈汉雄侯本新. NOBp1表达水平与乳腺癌临床病理因素及预后相关性[J]. 临床外科杂志, 2020, 28(9): 857-859.
[2]	王波董小林. 人G补缀FHA域血管生成因子1在三阴性乳腺癌的表达与预后的关系[J]. 临床外科杂志, 2020, 28(9): 860-863.
[3]	彭丰王敏谢昱秦仁义. 长链非编码RNA SNHG1在胆管癌中的表达与临床特征及预后的相关性分析[J]. 临床外科杂志, 2020, 28(8): 725-727.
[4]	王韬张峥嵘王少圣武健. 胆囊肉瘤样癌五例临床分析[J]. 临床外科杂志, 2020, 28(8): 744-746.
[5]	徐冉杨年钊赵海远李阳赵军张义胜. 多灶性胃癌病人淋巴结转移危险因素及预后分析[J]. 临床外科杂志, 2020, 28(8): 774-777.
[6]	袁俊李印彭银杰凃成志陈威鹏秦建军. 术前中性粒细胞与淋巴细胞比值对淋巴结转移的胸段食管鳞癌病人预后的预测价值[J]. 临床外科杂志, 2020, 28(7): 627-630.
[7]	李政委, 王杭州, 朱炳鑫等. 学龄前儿童中重型颅脑损伤预后不良相关因素分析[J]. 临床外科杂志, 2020, 28(6): 545-547.
[8]	韩加刚, 王振军. 梗阻性左半结肠癌治疗新策略-支架扩张联合新辅助化疗[J]. 临床外科杂志, 2020, 28(5): 401-403.
[9]	狄子杨, 唐强, 狄茂军等. 腹腔热灌注化疗治疗晚期结直肠癌的疗效分析[J]. 临床外科杂志, 2020, 28(5): 433-436.
[10]	蔡华霞, 王曙逢. 联合中性粒细胞/淋巴细胞比值与纤维蛋白原在分析胃肠道间质瘤预后中的价值[J]. 临床外科杂志, 2020, 28(5): 452-455.
[11]	查正彪, 潘友民, 郑智等. Stanford A型主动脉夹层术后急性肾功能损伤危险因素分析及预后[J]. 临床外科杂志, 2020, 28(5): 467-470.
[12]	王序杰, 周岩冰. 机器人直肠癌手术现状[J]. 临床外科杂志, 2020, 28(5): 489-492.
[13]	王马艳韩兴发. 腹壁炎性肌纤维母细胞瘤一例[J]. 临床外科杂志, 2020, 28(4): 398-398.
[14]	刘文胜. 复发性分化型甲状腺癌的诊治思路与规范[J]. 临床外科杂志, 2020, 28(3): 205-207.
[15]	俞庆华王兴旺战俣飞. ω-3鱼油脂肪乳联合早期肠内营养对重型颅脑创伤病人肠道功能及近期预后的影响[J]. 临床外科杂志, 2020, 28(3): 240-242.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed